Regular rerview: Improving the care of patients with genital herpes

British Medical Journal

Volumn 321, Issue 7261, 2000, Pages 619-623

  Drake, Susan ^a   Taylor, Stephen ^a   Brown, David ^b   Pillay, Deenan ^c  

^a BIRMINGHAM HEARTLANDS HOSPITAL   (United Kingdom)

^b CENTRAL PUBLIC HEALTH LABORATORY   (United Kingdom)

^c UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; ANTIVIRUS AGENT; FAMCICLOVIR; VALACICLOVIR; 2 AMINOPURINE; DRUG DERIVATIVE; VALINE;

CLINICAL FEATURE; DISEASE COURSE; DRUG EFFICACY; GENITAL HERPES; HERPES SIMPLEX VIRUS 1; HUMAN; IMMUNE DEFICIENCY; PATIENT CARE; PREGNANCY; PRIORITY JOURNAL; REVIEW; SEXUAL BEHAVIOR; UNITED KINGDOM; VIRUS PATHOGENESIS; ADULT; CESAREAN SECTION; DRUG ADMINISTRATION; FEMALE; HEALTH CARE QUALITY; MALE; NEWBORN; PATIENT EDUCATION; PEMPHIGOID GESTATIONIS; PREVALENCE; RECURRENT DISEASE;

2-AMINOPURINE; ACYCLOVIR; ADULT; ANTIVIRAL AGENTS; CESAREAN SECTION; DRUG ADMINISTRATION SCHEDULE; FEMALE; HERPES GENITALIS; HUMANS; IMMUNOCOMPROMISED HOST; INFANT, NEWBORN; MALE; PATIENT EDUCATION; PEMPHIGOID GESTATIONIS; PREGNANCY; PREVALENCE; QUALITY ASSURANCE, HEALTH CARE; RECURRENCE; VALINE;

EID: 0034626002     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (26)

1. 1 Mertz GJ, Schmidt O, Jourden JL. Frequency of acquisition of first episode genital infection with herpes simplex virus from symptomatic and asymptomatic source contacts. Sex Transm Dis 1985;12:33-9.
2. 2 Clinical Effectiveness Group (Association of Genitourinary Medicine and the Medical Society for the Study of Venereal Diseases). National guidelines for the management of genital herpes. Sex Transm Infect 1999;75:24-8S.
3. 3 Vyse AJ, Gay NJ, Slomka MJ, Gopal R, Gibbs T, Morgan-Capner P, et al. The burden of infection with HSV-1 and HSV-2 in England and Wales: implications for the changing epidemiology of genital herpes. Sex Transm Inf 2000;76:183-7.
4. 4 Johnson AM, Wadsworth J, Wellings K, Field J. Heterosexual practices. In: Sexual attitudes and lifestyles. Oxford: Blackwell, 1994:110-82.
5. 5 Benedetti J, Corey L, Ashley R. Recurrence rates in genital herpes after symptomatic first-episode infection. Ann Intern Med 1994;121:847-54.
6. 6 Cowan F, Johnson A, Ashley R, Corey L, Mindel A. Antibody to herpes simplex virus type 2 as serological marker of sexual lifestyle in populations. BMJ 1994;309:1325-33.
7. 7 Ades AE, Peckham CS, Dale GE, Best JM, Jeansson S. Prevalence of anti-bodies to herpes simplex virus types 1 and 2 in pregnant women, estimated rates of infection. J Epidemiol Community Health 1989;43:53-60.
8. 8 Fleming DT, McQuillan GM, Johnson RE, Nahmias AJ, Aral SO, Lee FK, et al. Herpes simplex virus type 2 in the United States, 1976 to 1994 [see comments]. N Engl J Med 1997;337:1105-11.
9. 9 Andria GM, Langenberg A, Corey L, Ashley R, Wai Ping Leong MS, Straus S. A prospective study of new infections with herpes simplex virus type 1 and type 2. N Engl J Med 1999;341:1432-8.
10. 10 Koutsky L, Stevens CE, Holmes KK, Ashley R, Kiviat NB, Critchlow CW, et al. Underdiagnosis of genital herpes by current clinical and viral-isolation procedures. N Eng J Med 1992;326:1533-9.
11. 11 Wald A, Zeh J, Selke S. Virological characteristics of subclinical and symptomatic genital herpes infection. N Engl J Med 1995;333:770-5.
12. 12 Wald A, Corey L, Cone R, Hobson A, Davis G, Zeh J, et al. Frequent genital herpes simplex virus 2 shedding in immunocompetent women. Effect of acyclovir treatment. J Clin Invest 1997;99:1092-7.
13. 13 Taylor S, Drake S, Pillay D. Genital herpes, "the new paradigm." J Clin Pathol 1999;52:1-4.
14. 14 Wald A, Zeh J, Barnum G. Suppression of sub-clinical shedding of herpes simplex virus type 2 with acyclovir. Ann Intern Med 1996;124:8-15.
15. 15 Smith JR, Cowan F, Munday PE. The management of herpes simplex virus infection in pregnancy. Br J Obstet Gynaecol 1998;105:255-60.
16. 16 Brown ZA, Selke S, Zeh J, Kopelman J, Maslow A, Ashley RL, et al. The acquisition of herpes simplex virus during pregnancy. N Engl J Med 1997;337:509-15.
17. 17 Tookey P, Peckham CS. Neonatal herpes simplex virus infection in the British Isles. Paediatr Perinat Epidemiol 1996;10:432-42.
18. 18 Brown ZA, Benedetti J, Ashley R, Burchett S, Selke S, Berry S, et al. Neonatal herpes simplex virus infection in relation to asymptomatic maternal infection at the time of labor. N Engl J Med 1991;324:1247-52.
19. 19 Gutierrez KM, Falkovitz Halpern MS, Maldonado Y, Arvin A. Epidemiology of neonatal herpes simplex virus infections in California from 1985 to 1995. J Infect Dis 1999;180:199-202.
20. 20 Brocklehurst P, Kinghorn GR, Carney O, Helson K, Ross E, Ellis E, et al. A randomised placebo controlled trial of suppressive aciclovir in late pregnancy in women with recurrent genital herpes infection. Br J Obstet Gynaecol 1998;105:275-80.
21. 21 Bagdades EK, Pillay D, Squire SB, O'Neill C, Johnson MA, Griffiths PD, et al. Relationship between herpes simplex virus ulceration and CD4 cell counts in patients with HIV infection. AIDS 1992;6:1317-20.
22. 22 Harden EA, Rybak RJ, Hartline C, Cnann JW, Hodges-Savola CA, Wetherall NT, et al. Cross susceptibility patterns and neuro-virulence of acyclovir-resistant herpes simplex (HSV) isolates collected in a national surveillance study. Antiviral Res 2000;46:A78.
23. 23 Fox PA, Barton SE, Francis N, Henderson DC, Pillay D, Johnson MA, et al. Chronic erosive herpes simplex virus infection of the penis: a possible immune reconstitution disease. HIV Med 1999;1:10-18.
24. 24 Safrin S, Crumpacker C, Chatis P, Davis R, Hafner R, Rush J, et al. A controlled trial comparing foscarnet with vidarabine for acyclovir resistant mucocutaneous herpes simplex in the acquired immunodeficiency syndrome. N Engl J Med 1991;325:551-5.
25. 25 Lalezari J, Schaker T, Feinberg J, Gathe J, Lee S, Cheung T, et al. A randomized, double blind, placebo-controlled trial of cidofovir gel for the treatment of acyclovir-unresponsive mucocutaneous herpes simplex virus. J Infect Dis 1997;176:892-8.
26. 26 Chakrabarti S, Pillay D, Ratcliffe D, Cane P, Collingham K, Milligan D. Herpes simplex virus infections in allogeneic stem cell transplant recipients: risk factors for antiviral resistance and its prognostic significance. J Infect Dis 2000;181:2055-8.